Literature DB >> 17245513

Clinical importance of preoperative detection of the apical lymph node metastasis in patients with breast carcinoma.

H E Güven1, H Bulak, S Turanli, S Oral.   

Abstract

INTRODUCTION: According to the revised staging system for breast cancer, the infraclavicular node status has become more important because the involvement of the apical nodes now changes the stage of the disease for all tumour sizes. In this study, we analysed the stage migration among our patients treated with mastectomy for breast cancer.
METHODS: 44 patients who were treated with modified radical mastectomy for breast cancer in our department during 2003 were reviewed for their clinicopathological features, including the status of the axillary lymph nodes.
RESULTS: 11 patients (25 percent) were reclassified as stage IIIC according to the new Tumour, Node and Metastasis (TNM) classification system of American Joint Committee on Cancer that was revised in 2002. The mean age was 40.2 years and the mean tumour size was 5 cm.
CONCLUSION: Patients with breast cancer should be properly staged preoperatively for choosing appropriate individual treatment, and more accurate evaluation of the infraclavicular region for metastatic lymph nodes should be done.

Entities:  

Mesh:

Year:  2007        PMID: 17245513

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  2 in total

1.  Preclinical evaluation of nuclear morphometry and tissue topology for breast carcinoma detection and margin assessment.

Authors:  Ndeke Nyirenda; Daniel L Farkas; V Krishnan Ramanujan
Journal:  Breast Cancer Res Treat       Date:  2010-05-06       Impact factor: 4.872

2.  Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System.

Authors:  Zhe Wang; Wei Chong; Huikun Zhang; Xiaoli Liu; Yawen Zhao; Zhifang Guo; Li Fu; Yongjie Ma; Feng Gu
Journal:  Front Cell Dev Biol       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.